Entecavir hydrate monohydrate AKSci P238 CAS: 209216-23-9

CAS NO: 209216-23-9
Entecavir hydrate monohydrate AKSci P238
Chemical Name: Entecavir hydrate
Molecular Formula: C12H17N5O4
Formula Weight: 295.3
CAS No.: 209216-23-9
Description Review
Description

Entecavir hydrate monohydrate is a potent antiviral medication used in the treatment of chronic hepatitis B virus (HBV) infection. The chemical name for this drug is 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one hydrate monohydrate. The molecular formula of Entecavir hydrate monohydrate is C12H15N5O3.H2O, and its molecular weight is 295.3 g/mol. The CAS number for this compound is 209216-23-9 and it is available under the brand name Baraclude.

Top Ten Keywords from Google

  1. Entecavir mechanism of action
  2. Entecavir hepatitis B
  3. Baraclude
  4. Entecavir dosage
  5. Entecavir side effects
  6. Entecavir resistance
  7. Entecavir cost
  8. Entecavir renal impairment
  9. Entecavir vs tenofovir
  10. Entecavir generic

Synonyms for Entecavir hydrate monohydrate

  • Entecavir monohydrate
  • Entecavir hydrate
  • Baraclude hydrate
  • BMS-200475 hydrate
  • 209216-23-9

Health Benefits of Entecavir hydrate monohydrate

Entecavir hydrate monohydrate is used in the treatment of chronic HBV infection. The medication acts by inhibiting the reverse transcriptase enzyme that is necessary for HBV replication. As a result, it can prevent the virus from multiplying and spreading throughout the body. Entecavir is effective in reducing viral load, which can lead to an improvement in liver function and a reduction in the progression of liver disease.

Potential Effects of Entecavir hydrate monohydrate

The main effect of Entecavir hydrate monohydrate is the inhibition of HBV replication. As a result, it can reduce the amount of virus present in the body, and this may lead to an improvement in liver function. Entecavir can reduce the risk of serious liver disease, including cirrhosis and liver cancer.

Product Mechanism

Entecavir inhibits the reverse transcriptase enzyme that is necessary for HBV replication. By blocking this enzyme, Entecavir can prevent the virus from replicating, reducing the amount of virus in the body, which may lead to an improvement in liver function.

Safety

Entecavir hydrate monohydrate is generally considered safe for most people, but it should be used with caution in patients with liver or kidney disease. Anyone who is allergic to the drug or its ingredients should not use this medication. Pregnant women and women who are breastfeeding should consult with their healthcare provider before starting treatment with Entecavir.

Side Effects

Entecavir hydrate monohydrate can cause mild to moderate side effects in some patients, including headache, fatigue, dizziness, nausea, vomiting, diarrhea, and abdominal pain. Rare side effects of Entecavir include severe liver damage, muscle pain, and weakness.

Dosing Information

The dosing of Entecavir hydrate monohydrate will depend on the condition being treated and the individual patient. The medication is usually taken orally once daily and should be taken on an empty stomach.

Conclusion

Entecavir hydrate monohydrate is a potent antiviral medication used in the treatment of chronic HBV infection. It works by inhibiting the virus's ability to replicate, reducing viral load, and improving liver function. Despite its efficacy, Entecavir can cause side effects in some people, particularly those with liver or kidney disease. Therefore, it should only be used under the guidance of a qualified healthcare provider

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code